NorthRock Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3M | Buy |
76,797
+1,759
| +2% | +$326K | 0.37% | 36 |
|
|
2025
Q1 | $15.7M | Buy |
75,038
+2,174
| +3% | +$455K | 0.53% | 29 |
|
|
2024
Q4 | $12.9M | Sell |
72,864
-1,139
| -2% | -$202K | 0.42% | 35 |
|
|
2024
Q3 | $14.6M | Sell |
74,003
-53
| -0.1% | -$10.5K | 0.48% | 30 |
|
|
2024
Q2 | $12.7M | Sell |
74,056
-101
| -0.1% | -$17.3K | 0.48% | 29 |
|
|
2024
Q1 | $13.5M | Buy |
74,157
+1,299
| +2% | +$237K | 0.52% | 30 |
|
|
2023
Q4 | $11.3M | Buy |
72,858
+49,769
| +216% | +$7.71M | 0.47% | 33 |
|
|
2023
Q3 | $3.44M | Buy |
23,089
+1,993
| +9% | +$297K | 0.36% | 34 |
|
|
2023
Q2 | $2.84M | Sell |
21,096
-5,239
| -20% | -$706K | 0.31% | 35 |
|
|
2023
Q1 | $4.2M | Buy |
26,335
+885
| +3% | +$141K | 0.45% | 30 |
|
|
2022
Q4 | $4.11M | Sell |
25,450
-4,675
| -16% | -$756K | 0.47% | 28 |
|
|
2022
Q3 | $4.04M | Sell |
30,125
-1,957
| -6% | -$263K | 0.47% | 29 |
|
|
2022
Q2 | $4.91M | Sell |
32,082
-3,434
| -10% | -$526K | 0.51% | 24 |
|
|
2022
Q1 | $5.76M | Sell |
35,516
-35,487
| -50% | -$5.75M | 0.52% | 26 |
|
|
2021
Q4 | $9.61M | Buy |
71,003
+2,421
| +4% | +$328K | 0.72% | 19 |
|
|
2021
Q3 | $7.5M | Buy |
68,582
+3,529
| +5% | +$386K | 0.61% | 22 |
|
|
2021
Q2 | $7.33M | Sell |
65,053
-141
| -0.2% | -$15.9K | 0.61% | 22 |
|
|
2021
Q1 | $7.06M | Sell |
65,194
-1,086
| -2% | -$118K | 0.64% | 21 |
|
|
2020
Q4 | $7.1M | Buy |
66,280
+1,902
| +3% | +$204K | 0.7% | 22 |
|
|
2020
Q3 | $5.64M | Buy |
64,378
+200
| +0.3% | +$17.5K | 0.63% | 23 |
|
|
2020
Q2 | $6.3M | Buy |
64,178
+2,476
| +4% | +$243K | 0.75% | 21 |
|
|
2020
Q1 | $4.7M | Buy |
61,702
+25,097
| +69% | +$1.91M | 0.66% | 27 |
|
|
2019
Q4 | $3.24M | Buy |
36,605
+13,151
| +56% | +$1.16M | 0.34% | 52 |
|
|
2019
Q3 | $1.78M | Buy |
+23,454
| New | +$1.78M | 0.24% | 63 |
|